on 08 Oct 2024
Last Applicant/ Owned by
185 South Avenue, TEDA West District
Tianjin
CN
300000
Serial Number
98189642 filed on 20th Sep 2023
Registration Number
7526930 registered on 08th Oct 2024
Correspondent Address
Paulo A. de Almeida
Filing Basis
No Filing Basis
Disclaimer
NO DATA
Pharmaceutical preparations, namely, antivirals; Chemical preparations for pharmaceutical purposes, namely, for the treatment of infectious diseases; Vaccines; Medicines for the treatment of infectious diseases; Cultures of microorganisms for medical or veterinary use; Chemical preparations for medical purposes, namely, for the treatment of infectious diseases; Injectable pharmaceuticals for treat Read More
Pharmaceutical preparations, namely, antivirals; Chemical preparations for pharmaceutical purposes, namely, for the treatment of infectious diseases; Vaccines; Medicines for the treatment of infectious diseases; Cultures of microorganisms for medical or veterinary use; Chemical preparations for medical purposes, namely, for the treatment of infectious diseases; Injectable pharmaceuticals for treatment of anaphylactic reactions; Drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; biochemical medicines for the treatment of infectious diseases, namely, biochemical reagents for medical purposes; Bacteriological culture mediums
N/A
N/A
No 98189642
No Service/Collective Mark
No
No
No
Yes
Yes
No
No
No
No
Status Date | Action Taken |
---|---|
08th Oct 2024 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
08th Oct 2024 | REGISTERED-PRINCIPAL REGISTER |
23rd Jul 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
23rd Jul 2024 | PUBLISHED FOR OPPOSITION |
03rd Jul 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
18th Jun 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
13th Jun 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
13th Jun 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
13th Jun 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
20th May 2024 | NON-FINAL ACTION WRITTEN |